Background of addressing the problem of antimicrobial resistance (AMR)
Antimicrobial resistance (AMR) is a real and immediate global threat.
The damaging effects caused by resistant pathogens are already responsible for an estimated 700,000 deaths per year globally, and future projections of the impact of unresolved AMR surpass the projected number of deaths caused by cancer by 2050. As AMR also could have a grave impact on the global economy, it potentially could pose a high direct and indirect cost to society.
WHO and United Nations Initiatives to Tackle AMR
WHO Global Action Plan
- Global cooperation spearheaded by World Health Assembly
- Global Action Plan setting out five strategic objectives
- 1Improving awareness and understanding of antimicrobial resistance
- 2Strengthening the knowledge and evidence base through surveillance and research
- 3Reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures
- 4Optimizing the use of antimicrobial agents in human and animal health
- 5Developing an economic case for sustainable investment
United Nations High-Level Meeting (September 2016)
- World leaders signaled an unprecedented level of attention to curb the spread of multidrug-resistant infections.
- Countries reaffirmed their commitment to develop national action plans on AMR.
- Leaders recognized the need for stronger systems to monitor drug-resistant infections and the volume of antimicrobials used in humans, animals and crops, as well as increased international cooperation and funding.
- Leaders also called for new incentives for investment in research and development of new, effective and affordable medicines, rapid diagnostic tests, and other important therapies to replace those that are losing their power.
WHO List of Antibiotic-Resistant “Priority Pathogens”
|Streptococcus pneumoniae||Streptococcus pneumoniae|